Team of the Year Award for Quotient

Drug development services provider Quotient Clinical has received a British Private Equity & Venture Capital Association (BVCA) Management Team Award.

Recognised as the outstanding business in the Large Company category, the national award was presented to Quotient’s CEO Mark Egerton and CFO Gordon Cameron, at an annual BVCA Gala Dinner held in London during December 2016.

Now in its eighth year, the BVCA Management Team Awards are the only awards to honour and reward the achievements and success of businesses across the UK which are backed by private equity and venture capital-backed management teams.

The judges commented: “The Quotient team under Mark Egerton are building a very exciting clinical services business, recognised in their sector by customers and competitors for developing a unique Translational Pharmaceutics solution others are unable to match. We admire their courage in investing heavily in this new approach and recognise the rewards they are achieving through rapid growth.”

Mark Egerton said: “I am very proud of everything that we have accomplished at Quotient. This award acknowledges all of the hard work and dedication of my colleagues within the company and the service they deliver to our customers. To gain recognition at a national level from the BVCA is a great achievement, and we look forward to continuing this success as the company evolves.”